| INTRODUCTION
Chronic Kidney Disease (CKD) is one of the essential public health problems worldwide. 1 Glomerular Filtration Rate (GFR) is the best index to evaluate the renal functions and determine the CKD. 2, 3 The measurement of GFR is important for the accurate assessment of risk, drug-dose adjustment, diagnosis and staging of renal disease. 4 GFR is calculated from clearances of exogenous substances such as inulin, iohexol, iotalamat. [5] [6] [7] But, these methods have limited use in clinical settings because of the difficulty of urine collection procedure, cost, and risk of radiation exposure. These methods are only suitable for research, not for routine use.
Serum and urine creatinine levels are the most common used tests to evaluate GFR and renal functions routinely. 8, 9 These are good markers of GFR because of low intra-individual variations, endogenously presence of creatinine, and full filtration from glomerular and no tubuler reabsorption. But, there are some disadvantages such as it is affected by age, sex, race, muscle mass, diet, exercise, thyroid functions, and extra-renal elimination and tubular secretion. [10] [11] [12] [13] Twenty four hours urine test is not recommended for GFR calculation because of urine collection errors, trouble to patients, incomplete bladder discharge and >25% of between-day variations of creatinine clearance. 14 
National Kidney Disease Education Program (NKDEP) Laboratory
Working Group, recommends the estimation of glomerular filtration rate based on serum creatinine values, using the Modification In our clinical laboratory, routine creatinine analysis is performed on automated analyzer based Jaffe method. In addition, we will plan to use enzymatic creatinine method on the same analyzer to meet the clinical requirements. In this study, we evaluated the analytical performance characteristics of the methods and compared the two creatinine methods based on Jaffe and enzymatic rate methods in serum and urine samples.
| MATERIALS AND METHODS

| Samples
Six different sample pools for precision studies were prepared at creatinine levels of 0.6, 1.6, 6.0 mg/dL for serum and 30, 60, 120 mg/dL for urine. The sample pools were stored for 20 days at −20°C until the time of analysis.
Serum and urine specimens were collected from 230 and 141 patients, respectively for whom a creatinine test was requested for routine analysis by Jaffe method. To perform comparison studies, left over samples from routine creatinine tests were used. No additional samples were collected, no medical-records reviewed or no contact with the patients were made, and no patient consent was obtained.
The samples were analyzed on the same day. They were not stored.
| Instrument, reagents and other materials
Two original creatinine reagent kit based on different methodology and 377) and calibrator for Jaffe method (Multi-constituent calibrator, catalog no. 1E65) and for serum enzymatic method (Clin Chem calibrator, catalog no. 6K30-10) and calibration factor for urine enzymatic method provided by the manufacturer were included in the study.
| Creatinine methods
Two automated creatinine methods based on Jaffe and enzymatic principle were performed. Jaffe creatinine method is based on alkaline picrate. At an alkaline pH, creatinine in the sample reacts with picrate to form a creatinine-picrate complex. The rate of increase in the absorbance at 500 nm because of the formation of this complex is directly proportional to the concentration of creatinine in the sample. The other creatinine method is based on enzymatic principle.
Creatinine in the sample is hydrolyzed by creatininase to creatine.
Creatine is in turn hydrolyzed by creatinase to sarcosine and urea.
Sarcosine from this reaction is oxidized by sarcosine oxidase to gly- The method parameters for serum and urine methods applied on the analyzer are summarized in Table 1 .
| Analytical performance studies
| Limit of Detection
We determined the LOD of each method by analyzing a zero calibrator 20 times and calculating a 3 SD limit.
| Limit of Quantitation
We determined the coefficient of variations (CVs) for the five sample pools that have a different creatinine concentration from each other.
The LOQs are defined as the minimum concentration at which CV is lower than 10%.
| Precision
We determined intra-assay coefficient of variations (CVs) on the same day by measuring one sample 20 times in one analytical run.
Inter-assay CVs were determined on 20 consecutive days on the basis of a single calibration.
| Linearity
Samples to test linearity were prepared from two serum and two urine pools. The low pool was prepared by mixing patient samples with creatinine concentrations of 0.1 mg/dL for serum and 0.25 mg/dL for urine. The high pool was prepared by mixing patient samples with creatinine concentrations of 65 mg/dL for serum and 260 mg/dL for urine. The high concentrated pool was diluted with the low concentrated pool to obtain the following final percentages of high pool:
100%, 90%, 80%, 40%, 20%, and 0%. Samples were analyzed in duplicate in one analytical run.
| Method comparison studies
Method comparison tests were performed according to the Clinical and Laboratory Standards Institute (CLSI) protocol. 22 Tests were con- The serum samples used for the method comparison study ranged from 0.22 mg/dL to 7.68 mg/dL and were selected as: 30% of total samples below 0.59 mg/dL, 40% at 0.6-1.6 mg/dL, and 30% of samples >1.6 mg/L. The urine samples ranged from 0.60 mg/dL to 331 mg/dL and were selected as: 36% of total samples below 29 mg/dL, 28% at 30-59 mg/dL, and 50% of samples >60 mg/dL.
| Statistical analyses
The MedCalc for Windows statistical package (MedCalc Software, Ostend, Belgium) was used to perform a descriptive statistical analysis. The slope, intercept, Sy|x, and r were estimated using PassingBablok regression analysis. Agreement between the methods was T A B L E 1 Summary of method parameters assessed visually using a Bland-Altman plot and the limits of agreement were also determined.
| RESULTS
The LODs for serum creatinine methods were defined as 0.01 mg/dL for both Jaffe and enzymatic methods. The LODs for urine creatinine methods were determined 0.25 mg/dL and 0.07 mg/dL for the Jaffe and the enzymatic method, respectively.
The intra-assay and inter-assay precision data are summarized in Table 2A ,B. All precision data were under desirable levels in both methods.
The LOQs were determined as the minimum concentrations at which CV were below 10%. The LOQs for serum enzymatic and Jaffe creatinine methods were the same, 0.05 mg/dL ( Figure 1A ). The urine enzymatic method had a lower LOQ than urine Jaffe method, with 0. T A B L E 2 Summary of intra-assay (A) and inter-assay (B) precision data
The limits of quantification for serum (A) and for urine (B) Jaffe and Enzymatic creatinine methods
| DISCUSSION
GFR is the best indicator of the renal functions. 8, 9 There are some reference methods to determine GFR, like inulin clearance and radiological methods. However, they are not suitable for routine analysis because of some difficulties in practice, like higher price and risk of radiation.
Serum and urine creatinine levels are used to determine GFR. Recently, nephrologists offer to use estimated GFR instead of 24-hours creatinine clearance or only serum creatinine levels. 23 Hence, nowadays, most clinical laboratories give e-GFR results automatically calculated by laboratory information systems in addition to serum creatinine results. 24, 25 With the increasing usage of e-GFR, questioning of analytical performance of creatinine methods started. 26, 27 So, a worldwide standardization program for creatinine methods were started by NKDEP and IFCC.
NKDEP also recommended that manufacturers should improve the analytical performance of their creatinine methods and clinical laboratories should increase the effective use of creatinine testing.
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Jaffe reaction is the most frequently used creatinine methods in the clinical laboratories, but it is affected by some non-creatinine chromogens. The other method for routine creatinine analysis is the enzymatic method. However, its usage is limited to point of care testing and dry chemistry, because it is 10-folds more expensive than Jaffe method. In this study, we compared the analytical performance and the patient results produced by both Jaffe and enzymatic creatinine methods dedicated for Abbott Architect analyzer.
LODs were the same in both serum creatinine methods, but enzymatic method had a lower LOD than Jaffe in urine. These lower limits could meet the current accepted analytical requirements. On the other hand, LOQ generally accepted as the minimum concentration where CV is lower than <10% is more important than LOD in clinical laboratories.
Both the two serum methods had a CV<10% at concentration of 0.05 mg/dL that was the minimum test point in this study. As seen Figure 1A , the enzymatic method had a better CV than Jaffe. Urine enzymatic method had a lower LOQ than Jaffe, but nonetheless Jaffe had a LOQ that meets the requirements for routine analysis ( Figure 1B ).
The linearity tests were carried out by dilutions of high concentrated pools with low concentrated pools. We found that both methods were linear up to 65 mg/dL and up to 260 mg/dL in serum and urine respectively (Figure 2A-D) . These upper measurement points were enough for routine analysis.
F I G U R E 2
The linearity for serum Jaffe method (A) (r=.9992), serum enzymatic method (B) (r=.9991), for urine Jaffe method (C) (r=.9999), urine enzymatic method (D) (r=.9999)
We found that both methods had a good precision at the three different concentrations of serum and urine pools as shown in Table 2A ,B, but enzymatic method had better precisions than Jaffe. The maximum intra-assay CVs for serum and urine were 1.45% and <1.52%, and the maximum inter-assay CVs for serum and urine were <2.65% and <2.28%. In general, it is accepted that maximum acceptable CV is less than one-half of intra-individual variations. 28 Intra-individual CV for serum creatinine obtained from the biological variation study is 5.95%, so desirable CV is <2.98%. 29 We found that intra-assay and inter-assay CVs were lower than desirable CVs in both serum and urine methods.
The differences between the results of enzymatic and Jaffe methods were determined by 230 serum and 141 urine sample according to CLSI guideline, EP09-A2-IR. 22 The higher correlations were defined by both of the methods in serum and in urine (r>.999) ( Figure 3A,B) . As seen in the Bland-Altman plot, Jaffe method gave the higher results than the enzymatic method, with an average of 4.2% and of 2.8%, in serum and in urine respectively ( Figure 4A,B) . As Bland-Altman plot is assessed visually, it is seen that the difference between the two method in serum are higher at concentrations of <1.0 mg/dL. The biases between the two methods in serum at concentrations of 0.6, 1.6, and 6.0 mg/dL were 7.03%, 0.85% and −1.86%, respectively. However, the Jaffe method in serum gave an average higher result of 7.03% than the enzymatic method at the concentration of 0.6 mg/dL, which is at the lower part of reference interval in men and women. The Jaffe method's mean higher result of 7.03% does not meet the desirable bias of 3.96%. 30 We calculated the total analytical error of the serum Jaffe as 11.4% at concentration of 0.6 mg/dL by using "Total Allowable Error (TEa)=bias%+1.65 CV%" formula. This TEa meets minimum allowable TEa (11.4%), but does not meet the desirable TEa (8.87%). 18 These results justify NKDEP's suggestions that offer the manufacturer to improve the analytical performance of their serum creatinine methods especially at concentrations of <1.0 mg/dL. Considering inter-assay CVs of serum Jaffe method are <2.65%, which is lower than desirable CVs, 18 it can be concluded that the biggest part of TEa is sourced from bias rather than CV.
Manufacturers adjust their method to IDMS to make a compensation of bias sourced from mainly non-creatinine chromogens, but it is obvious The other GFR marker, cystatin C, has been intensively investigated in the last decade. In many research, it is reported that serum cystatin C has some superiorities against serum creatinine in assessment of GFR: being not affected by length, mass, diet, age and sex, and constant production rate and constant serum levels after 1 year old.
However, there are some disadvantages of cystatin C like lower analytical performance, higher intra-individual variations and higher price (about 12-fold) then serum creatinine assays and there is no international standardization for cystatin C. [33] [34] [35] [36] [37] In addition, more studies are needed to define non-GFR determinant of cystatin C. Briefly, all existing data show that using cystatin C combine with serum creatinine will improve the accurate estimation of GFR.
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There are limitations in our study as we did not investigate the effect of interferance and different clinical conditions.
By this assessment with method evaluation and comparison data, both Jaffe and enzymatic methods were found to meet the analytical performance requirements for routine use. However, enzymatic method was found to have better performance in low creatine levels.
Jaffe method was found 7% higher in the lower limit of reference ranges.
If bias of the Jaffe method can be decreased to the desired level by manufacturers, this method will be used more safely in routine. In addition, since being ten-fold cheaper then enzymatic method, Jaffe method will remain as an important choice of clinical laboratories in the future.
